Fineline Cube

Follow:
14398 Articles
Sunshine Guojian Pharmaceutical Secures NMPA Approval for Clinical Trials of SSGJ-626 in Lupus Indications
CompanyDrug

Sunshine Guojian Pharmaceutical Secures NMPA Approval for Clinical Trials of SSGJ-626 in Lupus Indications

Zai Lab Reports Positive Phase III Results for KarXT, Showcasing Efficacy in Psychiatric Conditions
CompanyDrug

Zai Lab Reports Positive Phase III Results for KarXT, Showcasing Efficacy in Psychiatric Conditions

Sun-Novo Pharmaceuticals Gets Green Light for CAR-T Therapy Clinical Trial in Lupus Treatment
CompanyDrug

Sun-Novo Pharmaceuticals Gets Green Light for CAR-T Therapy Clinical Trial in Lupus Treatment

GSK Secures Global Rights to Chimagen Biosciences' T Cell-Engager in $850 Million Deal
CompanyDeals

GSK Secures Global Rights to Chimagen Biosciences’ T Cell-Engager in $850 Million Deal

Fosun Pharmaceutical Reports Q3 2024 Revenue Growth and R&D Progress
Company

Fosun Pharmaceutical Reports Q3 2024 Revenue Growth and R&D Progress

Shanghai Pharmaceuticals Reports Q3 2024 Revenue Growth, Strengthens Drug Pipeline
Company

Shanghai Pharmaceuticals Reports Q3 2024 Revenue Growth, Strengthens Drug Pipeline

Innovent Biologics' Picankibart Shows 64.6% Skin Clearance in Phase II Psoriasis Study
CompanyDrug

Innovent Biologics’ Picankibart Shows 64.6% Skin Clearance in Phase II Psoriasis Study

Livzon Pharmaceutical's Leuprorelin Acetate Microspheres Passes China's GQCE
CompanyDrug

Livzon Pharmaceutical’s Leuprorelin Acetate Microspheres Passes China’s GQCE

Xi'an Xintong Pharma's Pradefavir Wins NMPA Nod for Chronic Hepatitis B Treatment
CompanyDrug

Xi’an Xintong Pharma’s Pradefavir Wins NMPA Nod for Chronic Hepatitis B Treatment

Eli Lilly's Mounjaro Approved in Hong Kong for Obesity and Type 2 Diabetes Treatment
CompanyDrug

Eli Lilly’s Mounjaro Approved in Hong Kong for Obesity and Type 2 Diabetes Treatment

Clover Biopharmaceuticals Reports Strong Phase I Results for RSV Vaccine SCB-1019
CompanyDrug

Clover Biopharmaceuticals Reports Strong Phase I Results for RSV Vaccine SCB-1019

Merck and Moderna Launch Phase III Study for Individualized Neoantigen Therapy in Lung Cancer
CompanyDrug

Merck and Moderna Launch Phase III Study for Individualized Neoantigen Therapy in Lung Cancer